Companies / Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

Nasdaq: PLSECIK 1625101HAYWARD, CA

Financials · FY2025

Revenue$350.0K
Net income$-72.78M
Total debt
Cash$101.62M
Diluted EPS
Shares outstanding71.3M

Ownership

71.3M shares outstanding · as of Jul 31, 2026
67.7%Insiders
Ownership
Insiders67.68%48,269,731
Institutions10.22%7,287,809
Public float22.10%15,765,067

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Robert W. DugganDirector · 10% owner
67.60%48,211,433
Danahy Kevin PatrickChief Commercial Officer
0.06%43,298
Laviolette Paul aCEOChief Executive Officer · Director
0.02%15,000
Sainz MariaFormerDirector
Uecker DarrinChief Technology Officer · Director

Institutional holders 89

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 11, 2026Robert W. Duggan
Director
BuyCommon Stock$13.00M+660K
+1.39%
48,211,433
67.60% of shares
high
May 11, 2026Robert W. Duggan
Director
BuyCommon Stock$13.00M+660K
+1.38%
48,370,047
67.82% of shares
high
Feb 11, 2026Danahy Kevin Patrick
Executive
SellCommon Stock$504.0K-20K
-31.60%
43,298
0.06% of shares
medium
Feb 17, 2026Danahy Kevin Patrick
Executive
SellCommon Stock$472.6K-20K
-31.60%
43,298
0.06% of shares
medium
Feb 13, 2026Danahy Kevin Patrick
Executive
SellCommon Stock$470.6K-20K
-31.60%
43,298
0.06% of shares
medium
Feb 10, 2026Danahy Kevin Patrick
Executive
SellCommon Stock$470.4K-20K
-31.60%
43,298
0.06% of shares
medium
Feb 12, 2026Danahy Kevin Patrick
Executive
SellCommon Stock$467.4K-20K
-31.60%
43,298
0.06% of shares
medium
Feb 9, 2026Danahy Kevin Patrick
Executive
SellCommon Stock$429.0K-20K
-31.60%
43,298
0.06% of shares
medium

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PLSECommon StockEquity74587B101BBG00BRBHVD0